Home
>
National Drug Code (NDC)
>
Zafirlukast
Zafirlukast - 55111-626-30 - (Zafirlukast)
Drug Information of Zafirlukast
| Product NDC: | 55111-626 |
| Proprietary Name: | Zafirlukast |
| Non Proprietary Name: | Zafirlukast |
| Active Ingredient(s): | 20 mg/1 & nbsp; Zafirlukast |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zafirlukast
| Product NDC: | 55111-626 |
| Labeler Name: | Dr. Reddys Laboratories Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090372 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101118 |
Package Information of Zafirlukast
| Package NDC: | 55111-626-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (55111-626-30) |
NDC Information of Zafirlukast
| NDC Code | 55111-626-30 |
| Proprietary Name | Zafirlukast |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (55111-626-30) |
| Product NDC | 55111-626 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zafirlukast |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20101118 |
| Marketing Category Name | ANDA |
| Labeler Name | Dr. Reddys Laboratories Limited |
| Substance Name | ZAFIRLUKAST |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |
